![Meghan Bagshaw](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Meghan Bagshaw currently works at Sionna Therapeutics, Inc., as Vice President-Programs, Portfolio & Operations from 2022.
Ms. Bagshaw also formerly worked at SAGE Therapeutics, Inc., as Head-Program, Portfolio & Alliance Management.
Ms. Bagshaw received her undergraduate degree from Smith College.
| Sociétés | Poste | Début |
|---|---|---|
| SIONNA THERAPEUTICS, INC. | Directeur des opérations | 01/08/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Smith College
 Smith College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for CF and rare diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
